Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses
Milestone deal secures UK’s medicines access for patients, with a wide range of groundbreaking new treatments to reach NHS front-line quicker.
It’s hard to imagine how this will not mean changes to GLP1 supply and pricing going forward, it’s no coincidence this shake up/ shakedown of pricing happens with EL just shy of 3 months before “the deal” is announced. With new products on the way to market.
Smells fishy to me 🎣 and I know who is holding the rod
